Trintellix vs Lexapro: Cognition, Nausea, and Differences

Trintellix (vortioxetine) and Lexapro (escitalopram) are both approved only for major depressive disorder, but Trintellix acts on far more serotonin receptors, and it is the only one of the two with FDA-label data on a specific cognitive processing-speed benefit. This guide compares their mechanisms, side effects (particularly nausea and sexual dysfunction), the cognitive-function claim, dosing, and drug interactions.

This is general information, not medical advice. Neither drug should be started or stopped without a prescriber’s guidance.

Trintellix vs Lexapro at a glance

	Trintellix (vortioxetine)	Lexapro (escitalopram)
Drug class	“Multimodal” serotonergic antidepressant	SSRI
FDA-approved for	Major depressive disorder (adults) only	MDD (adults, adolescents 12-17), GAD (adults)
Serotonin receptor activity	SERT inhibition plus action at 5 additional serotonin receptor subtypes	SERT inhibition (selective)
Most common side effect	Nausea (dose-related, 15-20% in week one)	Nausea, insomnia
Cognitive claim	Label includes data on improved processing speed in acute MDD	No comparable specific cognitive claim
CYP2D6 interaction	Dose must be halved with strong CYP2D6 inhibitors; poor metabolizers capped at 10 mg	Weaker CYP2D6-related dose adjustment
Approved since	2013	2002 (original citalopram older; escitalopram 2002)

What each is approved for

Both are approved narrowly: Trintellix only for major depressive disorder in adults, and Lexapro for major depressive disorder in adults and adolescents 12 to 17, plus generalized anxiety disorder in adults. Neither has an OCD, panic disorder, or PTSD indication. If GAD is the diagnosis, Lexapro has an approval Trintellix lacks.

How they work: selective vs “multimodal”

Lexapro is a classic, selective SSRI: it binds with high selectivity to the serotonin transporter (SERT), blocking reuptake, with comparatively little direct action elsewhere.

Trintellix also strongly inhibits SERT, but its label and manufacturer materials describe additional activity at five other serotonin receptor subtypes: it is an antagonist at 5-HT3, 5-HT1D, and 5-HT7 receptors, a partial agonist at 5-HT1B receptors, and an agonist at 5-HT1A receptors. This combination of actions is the basis for calling it a “multimodal” antidepressant, distinct from a standard SSRI.

As with Viibryd’s added mechanism, the FDA label is careful about how much weight to put on this: the mechanism of the antidepressant effect of Trintellix is not fully understood, and the clinical relevance of the additional receptor activities is unknown. The multimodal profile is real and measurable in receptor-binding studies, but the label does not claim it makes Trintellix more effective than a standard SSRI overall; it is offered as a plausible explanation for some of the drug’s distinct side-effect and tolerability pattern, particularly around sexual function and cognition (below).

The cognitive processing-speed claim

This is one of the more distinctive, and more specifically FDA-recognized, differences between the two drugs. In May 2018, the FDA approved updated prescribing information for Trintellix that added new clinical trial data showing improvement in processing speed, described as an important aspect of cognitive function, in patients with acute major depressive disorder. This came from a supplemental new drug application specifically studying cognitive symptoms of depression, not just mood symptoms.

Head silhouette with a stopwatch icon representing the Trintellix processing speed claim

This does not mean Trintellix is marketed or approved as a cognitive enhancer for people without depression, and it is not indicated for cognitive impairment from other causes such as dementia. It means that within its approved population (adults with acute MDD), trial data specifically measured and found a processing-speed benefit, and this was significant enough for the FDA to add it to the official label. Lexapro’s label does not include a comparable, specifically studied cognitive claim.

Side effects

Trintellix’s most common adverse reactions, occurring in 5% or more of patients and at least twice the placebo rate, are nausea, constipation, and vomiting. Nausea is specifically dose-related and the most prominent issue: 15 to 20% of patients experience nausea within the first one to two days of treatment, and it is more common in women than men, though it is usually mild to moderate and the median duration is about two weeks, meaning it tends to improve rather than persist indefinitely. By the end of 6-to-8-week trials, roughly 10% of patients on 10 to 20 mg/day still had nausea.

Lexapro’s most common side effects are nausea and insomnia, along with the broader SSRI list: sexual dysfunction, sweating, and fatigue.

Sexual side effects: where Trintellix’s evidence is stronger

Both drugs can cause sexual dysfunction, and both labels warn about it. But this is one comparison where real head-to-head data exists rather than an inferred mechanism claim. A 2022 study specifically found vortioxetine superior to escitalopram across all measured sexual phases: desire, arousal, and orgasm. That is a directly comparative finding, not a theoretical inference from receptor pharmacology, which distinguishes this Trintellix-versus-SSRI comparison from the more speculative sexual-side-effect claims sometimes made for Viibryd.

Trintellix’s label also describes prospective studies specifically assessing sexual dysfunction, including in patients who developed treatment-emergent sexual dysfunction from a prior SSRI, a more rigorous evidence base for this particular claim than exists for most antidepressant comparisons.

Dosing

Trintellix starts at 10 mg once daily, without regard to meals, and is typically increased to 20 mg/day as tolerated. A lower dose of 5 mg/day can be considered for patients who do not tolerate higher doses. In known CYP2D6 poor metabolizers, the maximum recommended dose is 10 mg/day.

Lexapro starts at 10 mg once daily, increased to a maximum of 20 mg once daily after at least one week if needed, with 10 mg as the maximum in older adults.

Drug interactions

Trintellix’s dose must be reduced by half when co-administered with a strong CYP2D6 inhibitor (examples given in the label include bupropion, fluoxetine, paroxetine, and quinidine), since CYP2D6 is the primary enzyme that inactivates vortioxetine, and poor metabolizers already have roughly twice the plasma concentration of normal metabolizers. Conversely, when combined with a strong CYP inducer for more than 14 days, a dose increase up to three times the original dose may be considered. This makes Trintellix notably more sensitive to CYP2D6-related interactions in day-to-day dosing decisions than Lexapro.

Both drugs are contraindicated with MAOIs, raise serotonin syndrome risk with other serotonergic drugs, and increase bleeding risk with NSAIDs, aspirin, or anticoagulants. Both can cause low sodium (hyponatremia), particularly in older adults.

Screening before starting

Trintellix’s label specifically instructs screening for bipolar disorder prior to starting treatment, a standard antidepressant precaution shared across the class, including Lexapro, since starting an antidepressant in someone with undiagnosed bipolar disorder can trigger mania.

Stopping either drug

Trintellix’s manufacturer materials note that suddenly stopping the drug at higher doses may cause side effects including headache, stiff muscles, mood swings, sudden outbursts of anger, dizziness or lightheadedness, or a runny nose, standard SSRI-class discontinuation-type symptoms, though generally considered less severe than paroxetine’s profile. Lexapro carries similar general discontinuation advice: gradual dose reduction rather than abrupt stopping.

Practical tips for starting Trintellix

Take it with or without food; the label specifically notes it can be taken without regard to meals, unlike Viibryd.
Expect nausea in week one. Taking it with food, even though not required, sometimes helps individual tolerance, and the label’s own data shows nausea typically eases within about two weeks.
Give the antidepressant effect time. As with most antidepressants, meaningful improvement in mood typically takes several weeks at a stable dose.
List every other medicine you take, especially bupropion, fluoxetine, or paroxetine, since these require a Trintellix dose reduction.
Do not stop high doses abruptly. Ask your prescriber about a taper, especially if you have been on 15 or 20 mg.

Practical tips for starting Lexapro

Morning or evening, whichever suits your side-effect pattern. Some people find it activating and prefer morning dosing; others find it sedating and prefer evening.
The first two weeks are typically the hardest for side effects, before benefits become apparent.
Ask about the 20 mg cap and QT prolongation if you have any heart rhythm history, since escitalopram’s dose ceiling is specifically tied to this cardiac electrical concern in a way vortioxetine’s is not.
Report sexual side effects rather than just stopping, since dose adjustment or a switch (potentially to Trintellix, given its stronger comparative sexual-function data) may be considered.

What the broader antidepressant research says

In the large 2018 Cipriani network meta-analysis pooling 21 antidepressants across over 500 trials, both escitalopram and vortioxetine were generally found among the better-performing drugs on the combined measure of efficacy and tolerability, though vortioxetine’s more recent approval (2013) means it has a shorter track record and fewer trials feeding into such pooled analyses compared with escitalopram, which has been used since 2002. Neither drug has been shown to be clearly superior to the other in direct efficacy terms; the differences that matter most in practice are the ones covered above: side-effect pattern, the specific evidence on sexual function and cognition, and drug interaction complexity.

Who each might suit

Factors that may point toward Trintellix:

A history of sexual dysfunction on standard SSRIs, given the stronger comparative evidence here versus escitalopram specifically
Depression with prominent cognitive symptoms (slowed thinking, poor concentration), given the specific processing-speed data in its label
No CYP2D6-interacting medicines that would complicate its more sensitive dosing rules

Factors that may point toward Lexapro:

Generalized anxiety disorder alongside depression, since Lexapro has that additional approval
A preference for a longer-established, more predictable side-effect profile
Concurrent use of a strong CYP2D6 inhibitor where halving a Trintellix dose would add complexity
A teenager 12 to 17 with depression, since Lexapro has a specific pediatric indication that Trintellix does not

Frequently asked questions

Is Trintellix better than Lexapro for depression?

Neither is established as more effective overall. Trintellix has label-recognized data on a specific processing-speed cognitive benefit and stronger comparative evidence for fewer sexual side effects versus escitalopram specifically, which may matter for some patients, but this does not mean it is more effective for depression symptoms broadly.

Why does Trintellix cause so much nausea?

Its added activity at multiple serotonin receptors, beyond simple reuptake inhibition, is thought to contribute to a higher, dose-related rate of nausea, especially in the first one to two days of treatment. It typically improves within about two weeks.

Does Trintellix improve memory or focus?

Its label includes trial data showing improved processing speed in adults with acute major depressive disorder, which is a specific, studied claim, not a general cognitive-enhancement claim, and it applies within the context of treating depression, not as a standalone cognitive booster.

Can I take Trintellix with Prozac or Paxil?

Combining Trintellix with another strong CYP2D6 inhibitor such as fluoxetine or paroxetine requires halving the Trintellix dose, and combining any two serotonergic antidepressants raises serotonin syndrome risk. This combination should only be done under close medical supervision, if at all.

How long does Trintellix nausea last?

The label reports a median duration of about two weeks for nausea, usually mild to moderate in intensity, though about 10% of patients still reported it at the end of 6-to-8-week trials.

Is vortioxetine an SSRI?

It is sometimes loosely grouped with SSRIs because it strongly inhibits serotonin reuptake, but its manufacturer and the medical literature classify it separately as a multimodal antidepressant because of its additional receptor activities.